Drugmakers challenge paroxetine case at ECJ
Six pharmaceutical companies have questioned the UK Competition and Markets Authority’s framework for analysing pay-for-delay settlements, as the European Commission defended its national counterpart before the European Court of Justice.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.